Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Music Playlist Use in Clinical Trials of Psychedelic Assisted Psychotherapy: A Systematic ReviewJournal of Clinical Psychology · 2026-06-14Psilocybin in the Treatment of Cocaine Use DisorderJAMA Network Open · 2026-05-06SAT-219 Hepatic 5-HT2B receptor antagonism mediates the anti-steatotic and antifibrotic effects of psilocybin in preclinical MASH modelsJournal of Hepatology · 2026-04-30Severe Illness Associated with Eating Mushroom-Containing Chocolate Products - United States, January-October 2024.MMWR. Morbidity and mortality weekly report · 2026-04-08Psilocybin retail stores in Canada: Changes in availability, commercialization, and geographic distributionCanadian Journal of Public Health · 2026-03-18Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative reviewSchizophrenia Research · 2026-03-12Regulatory ambiguity and governance challenges for psilocybin mushrooms in BrazilInternational Journal of Drug Policy · 2026-02-17High hopes? Precision psychedelic addiction medicineFrontiers in Psychiatry · 2026-01-27The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidenceZenodo (CERN European Organization for Nuclear Research) · 2026-01-25Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N -Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain ExposureJournal of Medicinal Chemistry · 2026-01-25Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanismsRepository for Publications and Research Data (ETH Zurich) · 2026-01-19Intentions, Spirituality, Set, and Setting Are Associated with Mystical Experiences in Psilocybin-Assisted TherapyPsychedelic Medicine · 2026-01-11Pharmacological Management of Anxiety in End-of-Life Care: A Systematic Review of Benzodiazepines, Opioids, and PsilocybinHuman Psychopharmacology Clinical and Experimental · 2025-12-31Psilocybin elicits a conserved glucocorticoid-responsive gene signature across five 5-HT2A receptor-rich brain regions in ratActa Neuropsychiatrica · 2025-12-31Psilocybin as a Serotonergic Therapy in Epilepsy: Narrative Review of Therapeutic Potentials and Seizure RisksUnknown journal · 2025-12-28A Nature-Themed Video Intervention Increases Nature Relatedness in Psilocybin-Assisted Psychotherapy for Alcohol Use DisorderPsychedelic Medicine · 2025-12-25Effects of LSD and Psilocybin on Heart Rate in Patients Receiving Psychedelic Treatment for Depressive and Anxiety Disorders: A Retrospective Observational StudyPsychology International · 2025-12-18Psilocybin-assisted psychotherapy for treatment-resistant obsessive-compulsive disorder: protocol for an open-label pilot studyBJPsych Open · 2025-12-14Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxietyGeneral Hospital Psychiatry · 2025-12-08Psychedelics for the Treatment of Substance Use DisordersSUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice · 2025-11-30Best practices for first psychedelic experiences: harm reduction advice from the psychedelic communityHarm Reduction Journal · 2025-11-24Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trialPilot and Feasibility Studies · 2025-10-27A novel psychedelic 5-HT2A receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteerJournal of Psychopharmacology · 2025-10-15Zalsupindole is a Nondissociative, Nonhallucinogenic Neuroplastogen with Therapeutic Effects Comparable to Ketamine and PsychedelicsACS Chemical Neuroscience · 2025-10-12Understanding psilocybin mushrooms and aiding in setting standards for a burgeoning industry in JamaicaPhytochemistry Letters · 2025-09-30Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspringNature Communications · 2025-09-29Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of N,N-dimethyltryptamine and harmine in a meditation retreatUniversität Zürich, ZORA · 2025-09-28Active Constituents of Psilocybin Mushroom EdiblesJAMA Network Open · 2025-09-10Therapeutic Effects of Psychedelics and their Non-Hallucinogenic Analogs on Depressive-Like BehaviourCarleton undergraduate journal of science. · 2025-09-01Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case ReportPsychoactives · 2025-08-31Toward Standardized Products Containing Biomass of Psilocybe Cubensis FungiJournal of AOAC International · 2025-08-12Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stressTranslational Psychiatry · 2025-06-13Patients’ Attitudes Toward Hallucinogenic and Non-Hallucinogenic Psilocybin for Mental Health TreatmentJournal of Psychoactive Drugs · 2025-05-28FRI-407 Adding the serotonergic agonist psilocybin to semaglutide as a novel combination therapy to cure MASLDJournal of Hepatology · 2025-04-3013. Safety, Feasibility, and Tolerability of Psilocybin in Older Adults With Amnestic MCI: Preliminary Data From a SV2a PET Imaging StudyBiological Psychiatry · 2025-04-08Psilocybin Dispensaries and Online Health Claims in CanadaJAMA Network Open · 2025-03-31Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavementBMJ Open · 2025-03-31Psychedelics and chronic pain: self-reported outcomes on changed substance use patterns and health following naturalistic psychedelic useBritish Journal of Pain · 2025-02-10Beneficial effect of the combination psilocybin-semaglutide in a murine model of Steatotic Liver DiseaseDigestive and Liver Disease · 2025-01-31Direct effects of psilocybin on serotonin receptors regulate lipid accumulation in hepatic cells and adipocytesDigestive and Liver Disease · 2025-01-31Clinical use of psilocybin in mental disorders:: a bibliometric analysis in Scopus and Web of ScienceDialnet (Universidad de la Rioja) · 2024-12-31Narrative review of psilocybin, an important psychoactive substance with potential peri-anesthetic implicationsTrends in Anaesthesia and Critical Care · 2024-11-30Increased reactivity of the paraventricular nucleus of the hypothalamus and decreased threat responding in male rats following psilocin administrationUNC Libraries · 2024-10-21Moving psychedelic-assisted therapies from promising research into routine clinical practice: Lessons from the field of implementation scienceTranslational Behavioral Medicine · 2024-10-16PR012/#955 Psilocybin assisted psychotherapy for patients with ovarian caner: a subset analysis of a randomized, double-blind, placebo-controlled, phase II clinical trialInternational Journal of Gynecological Cancer · 2024-09-30Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreatJournal of Psychopharmacology · 2024-09-26Psilocybin legalization in the United States and psychological reactance: A test of evidence uncertainty, controlling language, and an ambiguous call to action.Motivation Science · 2024-09-22Going Underground: Demographics, Services, and Best Practices Endorsed by Practitioners Providing Support for Naturalistic Psychedelic UseJournal of Psychoactive Drugs · 2024-09-18Exploring U.K. cancer doctors’ attitudes toward psilocybin-assisted psychotherapy for cancer-related distressResearch Square · 2024-09-17Use of Psilocybin in the Treatment of Mental Disorders: Systematic Review of Clinal TrialsJournal of Complementary Medicine & Alternative Healthcare · 2024-09-16Fire Kasina advanced meditation produces experiences comparable to psychedelic and near-death experiences: A pilot studyEXPLORE · 2024-09-01Psychedelic-assisted therapy for palliative care within a home treatment setting: A case reportClinical Case Reports · 2024-08-29Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin ReceptorUNC Libraries · 2024-06-06THU-285 Lownonpsychedelic dosed of psilocybin for the therapy of MASLDJournal of Hepatology · 2024-05-31Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for DepressionPsychoactives · 2024-04-15Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditationScientific Reports · 2024-03-25Psychedelic substitution: altered substance use patterns following psychedelic use in a global surveyFrontiers in Psychiatry · 2024-02-21Non-psychedelic doses of psilocybin as a novel therapeutic approach for MASLDDigestive and Liver Disease · 2024-01-31Effect of a single psilocybin treatment on Fos protein expression in male rat brainNeuroscience · 2024-01-03Investigation of the structure, stability, and relative solubility of psilocybin in water and pure organic solvents: A molecular simulation studyJournal of Molecular Liquids · 2023-11-06Psilocybin, Depression, and Synaptogenesis: Insights into the Field’s Past, Present, and FutureGeorgetown Scientific Research Journal · 2023-10-09Therapeutic Potential of Psilocybin for Treating Psychological Distress among Survivors of Adverse Childhood Experiences: Evidence on Acceptability and Potential Efficacy of Psilocybin UseJournal of Psychoactive Drugs · 2023-10-09Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorderFrontiers in Psychiatry · 2023-09-17Potential Benefits of Psilocybin for Lupus Pain: A Case ReportCurrent Rheumatology Reviews · 2023-09-05Single-Dose Psilocybin Treatment for Major Depressive DisorderJAMA · 2023-08-30Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiencesScientific Reports · 2023-08-21Slouching towards engagement: interactions between people using psychedelics naturalistically and their healthcare providersFrontiers in Psychiatry · 2023-08-03Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trialBJPsych Open · 2023-06-30Health Benefits and Positive Acute Effects of Psilocybin Consumption: A Quantitative Textual Analysis of User Self-Reported DataJournal of Psychoactive Drugs · 2023-06-21Psilocybin intoxication did not affect daytime or sleep-related declarative memory consolidation in a small sample exploratory analysisEuropean Neuropsychopharmacology · 2023-06-16Psilocybin prevents reinstatement of alcohol seeking by disrupting the reconsolidation of alcohol-related memoriesPsychopharmacology · 2023-06-01The Effectiveness of Microdosed Psilocybin in the Treatment of Neuropsychiatric Lyme Disease: A Case StudyInternational Medical Case Reports Journal · 2023-02-28Optimizing outcomes in psilocybin therapy: Considerations in participant evaluation and preparationJournal of Affective Disorders · 2023-01-24Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigationComprehensive Psychoneuroendocrinology · 2022-12-05Music programming for psilocybin-assisted therapy: Guided Imagery and Music-informed perspectives.Frontiers in Psychology · 2022-11-16Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-16Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity.NeuroImage · 2022-07-01Production and extraction of psilocybin and psilocin from Psilocybe spp. mushroomsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-05Evaluation of a quantitative analytical method for psilocin and psilocybin using HPLC-DADRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-05Psychedelic medicines for mood disorders: current evidence and clinical considerations.PubMed · 2021-12-31A Complex Impact of Systemically Administered 5-HT2A Receptor Ligands on Conditioned Fear.The International Journal of Neuropsychopharmacology · 2021-08-31Effects of Psilocybin on Suicidal Ideation in Patients With Life-Threatening CancerBiological Psychiatry · 2021-04-26Effects of psilocybin-assisted therapy on treatment-resistant depressionEuropean Psychiatry · 2021-03-31Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.Australian & New Zealand Journal of Psychiatry · 2021-03-20"It kind of polishes all your flaws away": long-term experiences with psilocybin mushrooms and the influence of set and settingUnknown journal · 2020-12-31The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant ActionFrontiers in Pharmacology · 2020-12-02The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant ActionInstitutional Repositories DataBase (IRDB) · 2020-12-02Historic psychedelic drug trials and the treatment of anxiety disorders.Depression and anxiety · 2020-11-30Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humansJournal of Psychopharmacology · 2020-10-07A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor bindingEuropean Neuropsychopharmacology · 2020-03-03Microdosing psychedelics: Demographics, practices, and psychiatric comorbiditiesJournal of Psychopharmacology · 2020-02-27Self-reported negative outcomes of psilocybin users: A quantitative textual analysisPLoS ONE · 2020-02-20Transformative experience and social connectedness mediate the mood-enhancing effects of psychedelic use in naturalistic settingsProceedings of the National Academy of Sciences · 2020-01-20Medicinal use of psilocybin: Reducing restrictions on research and treatment.Unknown journal · 2019-12-31P.839 Modelling the acute temporal dynamics of psilocybin psychoactive effects; relation to brain serotonin 2a receptor levelsEuropean Neuropsychopharmacology · 2019-11-30Injury-Triggered Blueing Reactions of Psilocybe “Magic” MushroomsAngewandte Chemie · 2019-11-13Psychedelic microdosing benefits and challenges: an empirical codebookHarm Reduction Journal · 2019-07-08Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levelsNeuropsychopharmacology · 2019-01-25Psilocybin occupancy of brain serotonin 2A receptors correlates with psilocin levels and subjective experience: a [11C]Cimbi-36 PET study in humansEuropean Neuropsychopharmacology · 2018-12-31DARK Classics in Chemical Neuroscience: Psilocybin.Unknown journal · 2018-07-15High dose psilocybin is associated with positive subjective effects in healthy volunteers.Journal of Psychopharmacology · 2018-06-26Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers.Psychopharmacology · 2018-01-04Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.Clinical Pharmacokinetics · 2017-11-30Clinical potential of psilocybin as a treatment for mental health conditions.Mental Health Clinician · 2016-12-31[Trends in Abuse of Biogenic Drugs in Parts of Germany 2007-2013].Das Gesundheitswesen · 2016-06-13Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning.Experimental Brain Research · 2013-06-01Effects of the hallucinogenic 5-HT2A agonist psilocybin on object completion in humansInternational Journal of Psychophysiology · 2008-07-16Effects of psilocybin on time perception and temporal control of behaviour in humans.Queensland's institutional digital repository (The University of Queensland) · 2006-05-18177. NMDA and 5-HT2A receptor dysfunction in working memory deficits in schizophreniaBiological Psychiatry · 2000-03-31